Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4

ATPase associated with a variety of cellular activities (AAA ATPase) family members are closely linked to tumor formation and progression. However, their roles in hepatocellular carcinoma (HCC) largely remain ...

Source: Journal of Experimental and Clinical Cancer Research - September 18, 2019 Category: Cancer & Oncology Authors: Meng-Xuan Zhu, Chuan-Yuan Wei, Peng-Fei Zhang, Dong-Mei Gao, Jie Chen, Yan Zhao, Shuang-Shuang Dong and Bin-Bin Liu Tags: Research Source Type: research